Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Depreciation and Depletion (2020 - 2025)

Pulmonx (LUNG) has disclosed Depreciation and Depletion for 7 consecutive years, with $200000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation and Depletion fell 33.33% to $200000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $900000.0, a 25.0% decrease, with the full-year FY2024 number at $1.1 million, down 21.43% from a year prior.
  • Depreciation and Depletion was $200000.0 for Q3 2025 at Pulmonx, down from $300000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $400000.0 in Q2 2022 to a low of $100000.0 in Q1 2021.
  • A 5-year average of $273684.2 and a median of $300000.0 in 2021 define the central range for Depreciation and Depletion.
  • Peak YoY movement for Depreciation and Depletion: soared 300.0% in 2022, then crashed 66.67% in 2024.
  • Pulmonx's Depreciation and Depletion stood at $300000.0 in 2021, then skyrocketed by 33.33% to $400000.0 in 2022, then dropped by 25.0% to $300000.0 in 2023, then plummeted by 66.67% to $100000.0 in 2024, then surged by 100.0% to $200000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Depreciation and Depletion are $200000.0 (Q3 2025), $300000.0 (Q2 2025), and $300000.0 (Q1 2025).